The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP FIGI (to the nearest dollar) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
Adaptimmune Therapeutics plc Common 00653A107   4,713,719 5,095,912 SH   SOLE   5,095,912 0 0
Amicus Therapeutics Inc. Common 03152W109   6,482,706 516,139 SH   SOLE   516,139 0 0
Avadel Pharmaceuticals PLC Sponsored ADR 05337M104   6,344,635 384,990 SH   SOLE   384,990 0 0
Axsome Therapeutics, Inc. Common 05464T104   6,725,090 93,586 SH   SOLE   93,586 0 0
Chinook Therapeutics, Inc. Common 16961L106   38,550,859 1,003,406 SH   SOLE   1,003,406 0 0
Crinetics Pharmaceuticals Inc. Common 22663K107   8,632,535 479,053 SH   SOLE   479,053 0 0
Cullinan Oncology, Inc. Common 230031106   82,295,364 7,648,268 SH   SOLE   7,648,268 0 0
Edgewise Therapeutics Inc Common 28036F105   5,524,185 712,798 SH   SOLE   712,798 0 0
Geron Corporation Common 374163103   29,504,041 9,191,290 SH   SOLE   9,191,290 0 0
Harpoon Therapeutics, Inc. Common 41358P106   2,269,662 3,196,707 SH   SOLE   3,196,707 0 0
Inozyme Pharma Inc. Common 45790W108   1,820,950 326,921 SH   SOLE   326,921 0 0
Insmed Incorporated Common 457669307   11,177,577 529,743 SH   SOLE   529,743 0 0
Kalvista Pharmaceuticals Inc Common 483497103   6,853,842 761,538 SH   SOLE   761,538 0 0
Karuna Therapeutics Inc Common 48576A100   11,579,573 53,399 SH   SOLE   53,399 0 0
Intellia Therapeutics, Inc. Common 45826J105   22,210,378 544,639 SH   SOLE   544,639 0 0
Iovance Biotherapeutics Inc Common 462260100   20,768,831 2,950,118 SH   SOLE   2,950,118 0 0
iTeos Therapeutics, Inc. Common 46565G104   23,116,285 1,745,943 SH   SOLE   1,745,943 0 0
Iveric Bio Inc Common 46583P102   47,784,803 1,214,662 SH   SOLE   1,214,662 0 0
Madrigal Pharmaceuticals inc Common 558868105   8,780,541 38,011 SH   SOLE   38,011 0 0
Moonlake Immunotherapeutics Common 61559X104   15,050,661 295,111 SH   SOLE   295,111 0 0
Olema Pharmaceuticals, Inc. Common 68062P106   4,176,375 462,500 SH   SOLE   462,500 0 0
Oncorus, Inc. Common 68236R103   96,270 2,377,031 SH   SOLE   2,377,031 0 0
Phathom Pharmaceuticals inc Common 71722W107   4,042,994 282,332 SH   SOLE   282,332 0 0
Reata Pharmaceuticals, Inc. Common 75615P103   23,907,377 234,478 SH   SOLE   234,478 0 0
REGENXBIO Inc. Common 75901B107   13,127,793 656,718 SH   SOLE   656,718 0 0
Relay Therapeutics Inc. Common 75943R102   17,010,862 1,354,368 SH   SOLE   1,354,368 0 0
Repare Therapeutics, Inc. Common 760273102   17,349,602 1,639,849 SH   SOLE   1,639,849 0 0
Revolution Medicines, Inc. Common 76155X100   7,313,664 273,408 SH   SOLE   273,408 0 0
Travere Therapeutics Inc. Common 89422G107   8,491,715 552,846 SH   SOLE   552,846 0 0
Ventyx Biosciences Inc Common 92332V107   1,041,302 31,747 SH   SOLE   31,747 0 0
Verve Therapeutics, Inc Common 92539P101   16,086,375 857,940 SH   SOLE   857,940 0 0
Viridian Therapeutics Inc Common 92790C104   6,074,134 255,323 SH   SOLE   255,323 0 0
Xeris Biopharma Holdings Inc Common 98422E103   10,414,497 3,974,999 SH   SOLE   3,974,999 0 0
Werewolf Therapeutics, Inc. Common 95075A107   7,283,434 2,388,011 SH   SOLE   2,388,011 0 0